A refinement of quality indicators (QIs) is described whereby the quality of care can be measured across colposcopy services in different countries and healthcare settings.
A five-round Delphi process was conducted at successive satellite meetings from 2011 to 2015 of leading European colposcopists to refine the most high-scoring QIs relevant to colposcopic practice. A review and refinement of the wording of the standards and their criteria was undertaken by na-tional society representatives. Six quality indicators were identified and refined.
«Documentation of whether the squamocolumnar junction (SCJ) has been visible or not» was changed into «for cervical colposcopy transformation zone (TZ) type (1, 2 or 3) should be documented».
The standard «percentage of cases having a col-poscopic examination prior to treatment for abnormal cytology» was changed to «percentage of cases having a colposcopic examination prior to treatment for abnormal cervical screening test».
The standard «percentage of all excisional treatments/conizations containing CIN2+ (cervical intra-epithelial neoplasia grade two or worse)» was changed into «percentage of excisional treat-ments/conizations having a definitive histology of CIN2+. Definitive histology is highest grade from any diagnostic or therapeutic biopsies».
The standard «percentage of excised lesions/conizations with clear margins» was unchanged.
The remaining two QIs define the minimum caseloads required for colposcopists.
However, «cytology» was replaced by «screening results» to acknowledge the intro-duction of human papillomavirus testing to European screening programmes.
Six QIs were identified to define good practice in colposcopy.
Keywords: Colposcopy, Healthcare quality assurance, Early detection of cancer
K. Ulrich PetryCorrespondence information about the author K. Ulrich PetryEmail the author K. Ulrich Petry Email the author K. Ulrich Petry, Pekka J. Nieminen, Simon C. Leeson, Christine O.M.A. Bergeron, Charles W.E. Redman
EJOG, Volume 224, Pages 137−141